Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
Clinical trial NCT07071155 · RECRUITING
Trial details
- NCT number
- NCT07071155
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-19
- Primary completion
- 2028-03-05
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.